Novel TAP1 polymorphisms in indigenous Zimbabweans
Human Immunology, ISSN: 0198-8859, Vol: 64, Issue: 8, Page: 823-829
2003
- 10Citations
- 12Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations10
- Citation Indexes10
- CrossRef10
- 10
- Captures12
- Readers12
- 11
Article Description
Because of the essential role of transporter associated with antigen processing (TAP1 or TAP2) molecule in antigen processing, the implication of its polymorphism as a factor involved in human diseases and the possible genetic variation at this locus among ethnically diverse populations, we underwent a study to analyze the full extent of TAP1 polymorphism in an indigenous Zimbabwean population (Shona ethnic group). Using single-stranded conformation polymorphism and DNA direct sequencing procedures, we detected the presence of 11 nucleotide sequence variations in the entire coding region of TAP1. Of these variants, eight are nonconservative substitutions with respect to amino acid composition and are located in a critical part of the protein that could modulate its function. Five new polymorphic sites were identified in exon 1 (codons 7 Pro→Ser, 17 Gly→Arg, 141 Val→Val), exon 6 (codon 419 Gly→Cys), and exon 7 (codon 487 Arg→Arg). Significant differences were seen in the distribution of TAP1*0201 and TAP1*0401 alleles, and codon 333 (Ile→Val) polymorphism among African and non-African populations. Thus, TAP1 polymorphism has evolved differently among populations presumably because of the evolutionary pressures generated by prevalent pathogens in these geographically distinct regions.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0198885903001101; http://dx.doi.org/10.1016/s0198-8859(03)00110-1; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0041709441&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/12878362; https://linkinghub.elsevier.com/retrieve/pii/S0198885903001101; http://linkinghub.elsevier.com/retrieve/pii/S0198885903001101; http://api.elsevier.com/content/article/PII:S0198885903001101?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0198885903001101?httpAccept=text/plain; http://dx.doi.org/10.1016/s0198-8859%2803%2900110-1; https://dx.doi.org/10.1016/s0198-8859%2803%2900110-1
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know